Questions about AstraZeneca jab linger
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Tuesday
June 28, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
TUESDAY, JUNE 28, 2022
Questions about AstraZeneca jab linger

Coronavirus chronicle

BSS/AFP
05 April, 2021, 01:00 pm
Last modified: 05 April, 2021, 01:07 pm

Related News

  • France donates 2.12 million more AstraZeneca shots to Bangladesh
  • AstraZeneca therapy works against omicron; results mixed for Regeneron
  • Bangladesh gets over 8m AstraZeneca jabs from Japan, UK
  • Bangladesh gets over 4m Oxford-AstraZeneca jabs from UK
  • Norway, Sweden and Switzerland provide 1.2mn vaccine doses to Bangladesh

Questions about AstraZeneca jab linger

The European Medicines Agency — which has said that benefits outweigh risks such that the vaccine should remain in use — will provide an updated assessment next week

BSS/AFP
05 April, 2021, 01:00 pm
Last modified: 05 April, 2021, 01:07 pm
A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca
A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca

Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against Covid-19 are more frequent than in the general population, and what causes them if they are, have continued to undermine confidence in the beleaguered vaccine.

The European Medicines Agency — which has said that benefits outweigh risks such that the vaccine should remain in use — will provide an updated assessment next week.

What Has Been Observed?

The blood clots seen in a handful of people vaccinated with AstraZeneca are described by the French Medicines Agency (ANSM) as "highly untypical".

"This thrombosis of large veins is unusually located in the brain, and even more rarely in the digestive tract," the agency commented.

It is also associated with a condition characterised by abnormally low levels of platelets, which are small cell fragments in our blood that form clots to stop or prevent bleeding.

In mid-March Germany's medicines regulator, the Paul Ehrlich Institute (PEI), was the first national health authority to flag what they described as an aberrantly high number of cases involving these rare cerebral blood clots, mostly in younger and middle-aged women.

According to some specialists, this set of symptoms pointed to so-called disseminated intravascular coagulation (DIC), in which blood clots form throughout the body.

Also seen in extreme cases of sepsis, this condition involves "both thrombosis and haemorrhaging", Odile Launay, a member of the scientific body advising the French government on Covid-19 vaccines, told AFP.

Link With The Vaccine?

"A causal link with the vaccine is not proven but is possible, and further analysis is continuing," the EMA said last week.

The agency is scheduled to meet on the question from April 6-9. Other specialists were more categorical.

"We have to stop speculating on whether there is a link or not — all the cases showed these symptoms three to 10 days after inoculation with the AstraZeneca vaccine," Pal Andre Holme, who heads a team at Oslo National Hospital working on these cases, told Norwegian television.

"We have not found any other triggering factor."

Norway's national medicines agency backed this assessment, with one of their executives, Steinar Madsen, saying "there is probably a link with the vaccine".

For its part, France's ANSM — pointing to "the very unusual type of thrombosis, a similar clinical profile, and similar timing of onset" — said there was a "small" risk.

How Big Is The Risk?

As of March 31, the EMA identified 62 cases of cerebral venous sinus thrombosis (CVST) in the world — 44 of them in Europe — among 9.2 million doses of AstraZeneca administered.

Of those, 14 have resulted in death, though it is not possible to definitively attribute fatalities to this rare form of thrombosis, the head of the EMA, Emer Cooke, said last week in a videoconference.

The statistics, she added, are comprehensive, or close to it.

In Germany, there have been 31 suspected cases of CVST — 19 accompanied by a drop in blood platelets — with nine deaths, according to the Paul-Ehrlich Institute.

These cases were spread across 2.8 million AstraZeneca vaccine doses injected, or just over one case per 100,000 doses.

The comparable figures for France are 12 cases and four deaths out of 1.9 million doses, and for Norway, five cases and three deaths out of 120,000 doses.

Britain — where AstraZeneca has been administered more than in any other country — registered 30 cases as of Saturday, including seven fatalities, across a total of 18.1 million doses.

But as is true of all medications, risks must always be weighed against benefits.

"We would all prefer to have drugs that are 100 percent safe but they don't exist," Adam Finn, a professor of paediatrics at University of Bristol, told the London-based Science Media Centre last week, commenting on renewed bans of the AstraZeneca vaccine in Germany and elsewhere.

"Right now the biggest risk to our lives and livelihoods throughout the world is Covid-19," Finn added. "We need to stay focussed on the need to prevent it taking millions more human lives before it is brought under control and the only effective way to do that is through vaccination."

The EMA has consistently echoed this view.

"The benefits of the AstraZeneca vaccine in preventing Covid-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects," it said in statement on March 31. – Risk factors?

Most cases of cerebral thrombosis have occurred in those under 65, but it is impossible to draw any conclusions about age because the vaccine has been administered to date mostly among younger populations.

The fact that a majority of cases have been among women may simply reflect the fact the health sector — predominately women — was given priority for vaccination.

"At present the review has not identified any specific risk factors, such as age, gender or a previous medical history of clotting disorders for these very rare events," the EMA said.

Notwithstanding, after some countries temporarily paused the AstraZeneca jab in mid-March, several countries have now suspended the vaccine again.

Germany decided last week to ban its use for anyone under 60, while in Canada — as in France — the age threshold is 55. In Sweden the age cutoff is 65.

"We do not have just one vaccine, we have several," Sandra Ciesek, a professor of medical virology at the Goethe University Frankfurt, wrote in Science magazine.

"So, restricting the AstraZeneca vaccine to older people makes sense to me."

Norway and Sweden have taken the more radical step of suspending the AstraZeneca vaccine altogether.

Possible Explanations?

For the moment, there are only hypotheses, though the EMA is expected to suggest next week which are the more likely.

In a study released on March 28 that has not yet been peer-reviewed, German and Austrian researchers pointed to a known biological mechanism as a possible explanation for the apparent surge in atypical thrombosis.

The AstraZeneca vaccine, they wrote, is associated with a thrombosis disorder "that clinically resembles heparin-induced thrombocytopenia (HIT)".

HIT is a rare and serious reaction of the immune system to the anti- coagulant medication heparin.

The authors, led by Andreas Greinacher from the University of Greifswald, proposed a name for what they described as a new syndrome: "vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)."

Researchers at Oslo National Hospital had earlier suggested that cases might have been triggered by a "powerful immune response" to the vaccine.

An association of French scientists and doctors called "On the Side of Science" have said such an immune response could come from the accidental insertion of the needle into a vein in the upper arm, rather than muscle.

Top News

AstraZeneca Covid-19 Vaccine / AstraZeneca Plc / AstraZeneca vaccine / Oxford-AstraZeneca / Oxford-AstraZeneca vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • World Bank to give Bangladesh $18b IDA loans in next five years
    World Bank to give Bangladesh $18b IDA loans in next five years
  • Law enforcement officers work at the scene where people were found dead inside a trailer truck in San Antonio, Texas, US, 27 June, 2022. Photo: Reuters
    Over 40 migrants found dead in truck in US
  • Govt’s bank borrowing jumps in June
    Govt’s bank borrowing jumps in June

MOST VIEWED

  • Covid-19 deaths were reported from Gorakhpur, Jalaun, Bulandshahr, Kannauj, Sonbhadra, Gonda, Bhadohi, Basti, Kushinagar and Mau (HT Photo)
    India sees 45% jump in a day with 17,073 new Covid cases
  • A healthcare worker collects the nasal sample of a policeman for Covid testing in Jammu on Wednesday. (ANI Photo)
    India’s daily Covid tally declines with 15,940 cases, 20 new deaths added
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing says will reopen primary, secondary schools as Covid cases recede
  • Anthony Fauci  Photo: Collected
    Top US medical expert Fauci says he is 'example' for Covid-19 vaccinations
  • An observation room in a Covid-19 vaccination center at a municipal hospital in Pune, in May 2021.
Photographer: Dhiraj Singh/Bloomberg
    India records 17,336 new coronavirus cases, a four-month high
  • Gaming machines are seen at the casino of MGM Cotai in Macau, China February 13, 2018/ Reuters
    Macau extends Covid shutdown of city, casinos stay open

Related News

  • France donates 2.12 million more AstraZeneca shots to Bangladesh
  • AstraZeneca therapy works against omicron; results mixed for Regeneron
  • Bangladesh gets over 8m AstraZeneca jabs from Japan, UK
  • Bangladesh gets over 4m Oxford-AstraZeneca jabs from UK
  • Norway, Sweden and Switzerland provide 1.2mn vaccine doses to Bangladesh

Features

Redmi 10C- Best Budget smartphone with one (big) compromise

Redmi 10C- Best Budget smartphone with one (big) compromise

20h | Brands
Photo caption: Bondstein Technologies founders Mir Shahrukh Islam (left) and Zafir Shafiee Chowdhury. Photo: Noor-A-Alam

Bondstein Technologies: From Dhaka College science club to Forbes 30 under 30 list

20h | Panorama
Photo: Collected

Samsung Dryer: Taking clean clothes to a new level

22h | Brands
Transparent sticky notes. Photo: Collected

A new layer to annotations with transparent sticky notes

22h | Brands

More Videos from TBS

The dormant south is ablaze with new possibilities

The dormant south is ablaze with new possibilities

12h | Videos
Russian missiles strike Kyiv

Russian missiles strike Kyiv

13h | Videos
Savings, excess liquidity in banks declining, loan demands increasing

Savings, excess liquidity in banks declining, loan demands increasing

15h | Videos
Photo: TBS

The snakes of Chattogram University

17h | Videos

Most Read

1
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

2
Desco wanted to make a bold statement with their new head office building, a physical entity that would be a corporate icon. Photo: Courtesy
Habitat

Desco head office: When commitment to community and environment inspires architecture

3
Japan cancels financing Matarbari coal project phase 2
Bangladesh

Japan cancels financing Matarbari coal project phase 2

4
Photo: Courtesy
Corporates

Gree AC being used in all parts of Padma Bridge project

5
Photo: TBS
Infrastructure

Gains from Padma Bridge to cross $10b, hope experts

6
Photo: TBS
Bangladesh

Motorcycles banned on Padma Bridge 

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
Workers unload boats and stockpile sacks of paddy at the BOC Ghat paddy market on the bank of the River Meghna in Brahmanbaria’s Ashuganj, the largest paddy market in the eastern part of the country. This century-old market sells paddies worth Tk5-6 crore a day during the peak season. PHOTO: RAJIB DHAR

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net